Cyclo Therapeutics Stock Investor Sentiment

CYTH Stock  USD 0.77  0.03  3.75%   
Under 63% of all Cyclo Therapeutics' traders are looking to take a long position. The analysis of the overall investor sentiment regarding Cyclo Therapeutics suggests that some traders are interested. Cyclo Therapeutics' investing sentiment shows overall attitude of investors towards Cyclo Therapeutics.
  

Cyclo Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cyclo Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at news.google.com         
Cyclo Therapeutics extends merger agreement with Rafael Holdings - Investing.com
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Fine N Scott of 299402 shares of Cyclo Therapeutics at 0.71 subject to Rule 16b-3
Macroaxis News
over three weeks ago at businesswire.com         
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
businesswire News
over three weeks ago at businesswire.com         
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
businesswire News
over three weeks ago at businesswire.com         
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
businesswire News
over three weeks ago at finance.yahoo.com         
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
Yahoo News
over three weeks ago at businesswire.com         
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
businesswire News
over three weeks ago at investing.com         
Cyclo Therapeutics faces Nasdaq delisting over meeting lapse
Investing News at Macroaxis
over a month ago at news.google.com         
Cyclo Therapeutics, Inc. announced that it has received 1 million in funding - Marketscreener.com
Google News at Macroaxis
over a month ago at investing.com         
Cyclo Therapeutics inks 3M convertible note with Rafael Holdings
Investing News at Macroaxis
over a month ago at gurufocus.com         
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
HAREHOLDER INVESTIGATION The MA Class Action Firm Continues to Investigate the Mergers ...
Gurufocus Stories at Macroaxis
over two months ago at thelincolnianonline.com         
Cyclo Therapeutics Trading Up 3 percent Heres What Happened
news
over two months ago at www.macroaxis.com         
Acquisition by Conkling William of 2449 shares of Cyclo Therapeutics subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Acquisition by Wong Vivien of 15145 shares of Cyclo Therapeutics subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Cyclo Therapeutics that are available to investors today. That information is available publicly through Cyclo media outlets and privately through word of mouth or via Cyclo internal channels. However, regardless of the origin, that massive amount of Cyclo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cyclo Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cyclo Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cyclo Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cyclo Therapeutics alpha.

Cyclo Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/14/2024
2
Acquisition by Conkling William of 2449 shares of Cyclo Therapeutics subject to Rule 16b-3
11/15/2024
3
Cyclo Therapeutics Trading Up 3 percent Heres What Happened
11/21/2024
4
Cyclo Therapeutics inks 3M convertible note with Rafael Holdings
01/03/2025
5
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium 2025
01/14/2025
6
Acquisition by Fine N Scott of 299402 shares of Cyclo Therapeutics at 0.71 subject to Rule 16b-3
01/29/2025
7
Cyclo Therapeutics extends merger agreement with Rafael Holdings - Investing.com
02/04/2025

Complementary Tools for Cyclo Stock analysis

When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon